ARTICLE | Clinical News

Arimidex anastrozole: Marketed to treat post-menopausal hormone-receptor positive breast cancer and advanced breast cancer that has progressed following tamoxif

May 19, 2003 7:00 AM UTC

AZN said that the Technology Assessment Working Group of the American Society of Clinical Oncology (ASCO) voted to maintain their recommendation to use Arimidex after reviewing 47-month follow-up data...